Jun 01, 2023
Ahmed W. Moawad, Anastasia Janas, Ujjwal Baid, Divya Ramakrishnan, Leon Jekel, Kiril Krantchev, Harrison Moy, Rachit Saluja, Klara Osenberg, Klara Wilms, Manpreet Kaur, Arman Avesta, Gabriel Cassinelli Pedersen, Nazanin Maleki, Mahdi Salimi, Sarah Merkaj, Marc von Reppert, Niklas Tillmans, Jan Lost, Khaled Bousabarah, Wolfgang Holler, MingDe Lin, Malte Westerhoff, Ryan Maresca, Katherine E. Link, Nourel hoda Tahon, Daniel Marcus, Aristeidis Sotiras, Pamela LaMontagne, Strajit Chakrabarty, Oleg Teytelboym, Ayda Youssef, Ayaman Nada, Yuri S. Velichko, Nicolo Gennaro, Connectome Students, Group of Annotators, Justin Cramer, Derek R. Johnson, Benjamin Y. M. Kwan, Boyan Petrovic, Satya N. Patro, Lei Wu, Tiffany So, Gerry Thompson, Anthony Kam, Gloria Guzman Perez-Carrillo, Neil Lall, Group of Approvers, Jake Albrecht, Udunna Anazodo, Marius George Lingaru, Bjoern H Menze, Benedikt Wiestler, Maruf Adewole, Syed Muhammad Anwar, Dominic Labella, Hongwei Bran Li, Juan Eugenio Iglesias, Keyvan Farahani, James Eddy, Timothy Bergquist, Verena Chung, Russel Takeshi Shinohara, Farouk Dako, Walter Wiggins, Zachary Reitman, Chunhao Wang, Xinyang Liu, Zhifan Jiang, Koen Van Leemput, Marie Piraud, Ivan Ezhov, Elaine Johanson, Zeke Meier, Ariana Familiar, Anahita Fathi Kazerooni, Florian Kofler, Evan Calabrese, Sanjay Aneja, Veronica Chiang, Ichiro Ikuta, Umber Shafique, Fatima Memon, Gian Marco Conte, Spyridon Bakas, Jeffrey Rudie, Mariam Aboian
Clinical monitoring of metastatic disease to the brain can be a laborious and time-consuming process, especially in cases involving multiple metastases when the assessment is performed manually. The Response Assessment in Neuro-Oncology Brain Metastases (RANO-BM) guideline, which utilizes the unidimensional longest diameter, is commonly used in clinical and research settings to evaluate response to therapy in patients with brain metastases. However, accurate volumetric assessment of the lesion and surrounding peri-lesional edema holds significant importance in clinical decision-making and can greatly enhance outcome prediction. The unique challenge in performing segmentations of brain metastases lies in their common occurrence as small lesions. Detection and segmentation of lesions that are smaller than 10 mm in size has not demonstrated high accuracy in prior publications. The brain metastases challenge sets itself apart from previously conducted MICCAI challenges on glioma segmentation due to the significant variability in lesion size. Unlike gliomas, which tend to be larger on presentation scans, brain metastases exhibit a wide range of sizes and tend to include small lesions. We hope that the BraTS-METS dataset and challenge will advance the field of automated brain metastasis detection and segmentation.
Via